• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Protocol: mixed-methods study to evaluate implementation, enforcement, and outcomes of U.S. state laws intended to curb high-risk opioid prescribing.方案:旨在评估美国各州旨在遏制高危阿片类药物处方的法律的实施、执行和结果的混合方法研究。
Implement Sci. 2018 Feb 26;13(1):37. doi: 10.1186/s13012-018-0719-8.
2
Implementation and enforcement of state opioid prescribing laws.州阿片类药物处方法律的实施与执行。
Drug Alcohol Depend. 2020 Aug 1;213:108107. doi: 10.1016/j.drugalcdep.2020.108107. Epub 2020 Jun 11.
3
Effect of Florida's Prescription Drug Monitoring Program and Pill Mill Laws on Opioid Prescribing and Use.佛罗里达州的处方药监测计划和“药丸工厂”法对阿片类药物处方和使用的影响。
JAMA Intern Med. 2015 Oct;175(10):1642-9. doi: 10.1001/jamainternmed.2015.3931.
4
Effects of State Opioid Prescribing Laws on Use of Opioid and Other Pain Treatments Among Commercially Insured U.S. Adults.州级阿片类药物处方法规对美国商业保险成年人群体中阿片类药物和其他疼痛治疗药物使用的影响。
Ann Intern Med. 2022 May;175(5):617-627. doi: 10.7326/M21-4363. Epub 2022 Mar 15.
5
Effect of pill mill laws on opioid overdose deaths in Ohio & Tennessee: A mixed-methods case study.俄亥俄州和田纳西州“毒品压片机法”对阿片类药物过量死亡的影响:一项混合方法案例研究。
Prev Med. 2019 Sep;126:105736. doi: 10.1016/j.ypmed.2019.05.024. Epub 2019 May 29.
6
Changes in opioid prescribing after implementation of mandatory registration and proactive reports within California's prescription drug monitoring program.加利福尼亚州处方药物监测计划实施强制性登记和主动报告后,阿片类药物处方的变化。
Drug Alcohol Depend. 2021 Jan 1;218:108405. doi: 10.1016/j.drugalcdep.2020.108405. Epub 2020 Nov 12.
7
Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.受控物质处方模式 - 处方行为监测系统,八个州,2013 年。
MMWR Surveill Summ. 2015 Oct 16;64(9):1-14. doi: 10.15585/mmwr.ss6409a1.
8
Systematic Evaluation of State Policy Interventions Targeting the US Opioid Epidemic, 2007-2018.系统评价针对美国阿片类药物流行的国家政策干预措施,2007-2018 年。
JAMA Netw Open. 2021 Feb 1;4(2):e2036687. doi: 10.1001/jamanetworkopen.2020.36687.
9
Association of the Use of a Mandatory Prescription Drug Monitoring Program With Prescribing Practices for Patients Undergoing Elective Surgery.强制性处方药物监测计划的使用与择期手术患者的处方实践之间的关联。
JAMA Surg. 2018 Dec 1;153(12):1105-1110. doi: 10.1001/jamasurg.2018.2666.
10
Effects of mandatory prescription drug monitoring program (PDMP) use laws on prescriber registration and use and on risky prescribing.强制性处方药物监测计划(PDMP)使用法规对开方者登记和使用以及高风险处方的影响。
Drug Alcohol Depend. 2019 Jun 1;199:1-9. doi: 10.1016/j.drugalcdep.2019.02.010. Epub 2019 Mar 22.

引用本文的文献

1
Design considerations for developing measures of policy implementation in quantitative evaluations of public health policy.在公共卫生政策定量评估中制定政策实施措施的设计考量
Front Health Serv. 2024 Jul 15;4:1322702. doi: 10.3389/frhs.2024.1322702. eCollection 2024.
2
Effects of Opioid Prescribing Cap Laws on Opioid and Other Pain Treatments Among Persons with Chronic Pain.阿片类药物处方限制法对慢性疼痛患者阿片类药物和其他疼痛治疗的影响。
J Gen Intern Med. 2023 Mar;38(4):929-937. doi: 10.1007/s11606-022-07796-8. Epub 2022 Sep 22.
3
Trends in opioid and non-opioid treatment for chronic non-cancer pain and cancer pain among privately insured adults in the United States, 2012-2019.2012-2019 年美国私人保险成年人慢性非癌症疼痛和癌症疼痛的阿片类药物和非阿片类药物治疗趋势。
PLoS One. 2022 Aug 10;17(8):e0272142. doi: 10.1371/journal.pone.0272142. eCollection 2022.
4
Effects of state opioid prescribing cap laws on opioid prescribing after surgery.州级阿片类药物处方限额法对术后阿片类药物处方的影响。
Health Serv Res. 2022 Oct;57(5):1154-1164. doi: 10.1111/1475-6773.14023. Epub 2022 Jul 29.
5
Association of Opioid Dose Reduction With Opioid Overdose and Opioid Use Disorder Among Patients Receiving High-Dose, Long-term Opioid Therapy in North Carolina.北卡罗来纳州接受高剂量、长期阿片类药物治疗的患者中,阿片类药物剂量减少与阿片类药物过量和阿片类药物使用障碍的关联。
JAMA Netw Open. 2022 Apr 1;5(4):e229191. doi: 10.1001/jamanetworkopen.2022.9191.
6
Effects of State Opioid Prescribing Laws on Use of Opioid and Other Pain Treatments Among Commercially Insured U.S. Adults.州级阿片类药物处方法规对美国商业保险成年人群体中阿片类药物和其他疼痛治疗药物使用的影响。
Ann Intern Med. 2022 May;175(5):617-627. doi: 10.7326/M21-4363. Epub 2022 Mar 15.
7
Implementation of mandatory opioid prescribing limits in North Carolina: healthcare administrator and prescriber perspectives.北卡罗来纳州实施强制性阿片类药物处方限制:医疗保健管理人员和处方者的观点。
BMC Health Serv Res. 2021 Nov 3;21(1):1191. doi: 10.1186/s12913-021-07230-5.
8
Co-Occurring Opioid Use and Depressive Disorders: Patient Characteristics and Co-Occurring Health Conditions.阿片类药物共同使用与抑郁障碍:患者特征和共同存在的健康状况。
J Dual Diagn. 2021 Oct-Dec;17(4):296-303. doi: 10.1080/15504263.2021.1979349. Epub 2021 Sep 28.
9
Methodological Challenges and Proposed Solutions for Evaluating Opioid Policy Effectiveness.评估阿片类药物政策有效性的方法学挑战与建议解决方案
Health Serv Outcomes Res Methodol. 2021 Mar;21(1):21-41. doi: 10.1007/s10742-020-00228-2. Epub 2020 Nov 12.
10
Effects of Implementation and Enforcement Differences in Prescription Drug Monitoring Programs in 3 States: Connecticut, Kentucky, and Wisconsin.康涅狄格州、肯塔基州和威斯康星州三个州处方药监测项目实施与执行差异的影响
Subst Abuse. 2021 Mar 25;15:1178221821992349. doi: 10.1177/1178221821992349. eCollection 2021.

本文引用的文献

1
Mortality in the United States, 2016.美国2016年的死亡率
NCHS Data Brief. 2017 Dec(293):1-8.
2
Treatment of Low Back Pain.腰痛的治疗
JAMA. 2017 Aug 22;318(8):743-744. doi: 10.1001/jama.2017.9386.
3
Noninvasive Treatments for Acute, Subacute, and Chronic Low Back Pain: A Clinical Practice Guideline From the American College of Physicians.非侵入性治疗急性、亚急性和慢性下背痛:美国医师学院临床实践指南。
Ann Intern Med. 2017 Apr 4;166(7):514-530. doi: 10.7326/M16-2367. Epub 2017 Feb 14.
4
Increases in Drug and Opioid-Involved Overdose Deaths - United States, 2010-2015.药物和阿片类药物滥用相关过量死亡人数增加 - 美国,2010-2015 年。
MMWR Morb Mortal Wkly Rep. 2016 Dec 30;65(50-51):1445-1452. doi: 10.15585/mmwr.mm655051e1.
5
Mandatory Provider Review And Pain Clinic Laws Reduce The Amounts Of Opioids Prescribed And Overdose Death Rates.强制医疗服务提供者审查和疼痛诊所法律降低了阿片类药物的处方量和过量死亡率。
Health Aff (Millwood). 2016 Oct 1;35(10):1876-1883. doi: 10.1377/hlthaff.2016.0448.
6
Opportunities to Improve Decision-Making About Opioid Prescribing.改善阿片类药物处方决策的机会。
J Gen Intern Med. 2017 Jan;32(1):3-5. doi: 10.1007/s11606-016-3847-3.
7
Nonmedical Prescription Opioid Use and DSM-5 Nonmedical Prescription Opioid Use Disorder in the United States.美国的非医疗处方阿片类药物使用及《精神疾病诊断与统计手册》第五版中的非医疗处方阿片类药物使用障碍
J Clin Psychiatry. 2016 Jun;77(6):772-80. doi: 10.4088/JCP.15m10386.
8
State Legal Restrictions and Prescription-Opioid Use among Disabled Adults.成年残疾人的州法律限制与处方阿片类药物使用
N Engl J Med. 2016 Jul 7;375(1):44-53. doi: 10.1056/NEJMsa1514387. Epub 2016 Jun 22.
9
Prescription Drug Monitoring Programs Are Associated With Sustained Reductions In Opioid Prescribing By Physicians.处方药监测项目与医生持续减少阿片类药物处方量有关。
Health Aff (Millwood). 2016 Jun 1;35(6):1045-51. doi: 10.1377/hlthaff.2015.1673.
10
Impact of prescription drug monitoring programs and pill mill laws on high-risk opioid prescribers: A comparative interrupted time series analysis.处方药监测计划和“药丸磨坊”法对高风险阿片类药物开处方者的影响:一项比较中断时间序列分析
Drug Alcohol Depend. 2016 Aug 1;165:1-8. doi: 10.1016/j.drugalcdep.2016.04.033. Epub 2016 Jun 2.

方案:旨在评估美国各州旨在遏制高危阿片类药物处方的法律的实施、执行和结果的混合方法研究。

Protocol: mixed-methods study to evaluate implementation, enforcement, and outcomes of U.S. state laws intended to curb high-risk opioid prescribing.

机构信息

, Baltimore, USA.

出版信息

Implement Sci. 2018 Feb 26;13(1):37. doi: 10.1186/s13012-018-0719-8.

DOI:10.1186/s13012-018-0719-8
PMID:29482599
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5828404/
Abstract

BACKGROUND

The U.S. opioid epidemic has been driven by the high volume of opioids prescribed by healthcare providers. U.S. states have recently enacted four types of laws designed to curb high-risk prescribing practices, such as high-dose and long-term opioid prescribing, associated with opioid-related mortality: (1) mandatory Prescription Drug Monitoring Program (PDMP) enrollment laws, which require prescribers to enroll in their state's PDMP, an electronic database of patients' controlled substance prescriptions, (2) mandatory PDMP query laws, which require prescribers to query the PDMP prior to prescribing an opioid, (3) opioid prescribing cap laws, which limit the dose and/or duration of opioid prescriptions, and (4) pill mill laws, which strictly regulate pain clinics to prevent nonmedical opioid prescribing. Some pain experts have expressed concern that these laws could negatively affect pain management among patients with chronic non-cancer pain. This paper describes the protocol for a mixed-methods study analyzing the independent effects of these four types of laws on opioid prescribing patterns and chronic non-cancer pain treatment, accounting for variation in implementation and enforcement of laws across states.

METHODS

Many states have enacted multiple opioid prescribing laws at or around the same time. To overcome this issue, our study focuses on 18 treatment states that each enacted a single law of interest, and no other potentially confounding laws, over a 4-year period (2 years pre-/post-law). Qualitative interviews with key leaders in each of the 18 treatment states will characterize the timing, scope, and strength of each state law's implementation and enforcement. This information will inform the design and interpretation of synthetic control models analyzing the effects of each of the two types of laws on two sets of outcomes: measures of (1) high-risk opioid prescribing and (2) non-opioid treatments for chronic non-cancer pain.

DISCUSSION

Study of mandatory PDMP enrollment, mandatory PDMP query, opioid prescribing cap, and pill mill laws is timely given a dynamic policy environment in which numerous states pass, revise, implement, and enforce varied laws to address opioid prescribing each year. Findings will inform enactment, implementation, and enforcement of these laws in additional states.

摘要

背景

美国的阿片类药物泛滥是由医疗保健提供者开出的大量阿片类药物推动的。美国各州最近颁布了四种旨在遏制与阿片类药物相关死亡率相关的高风险处方实践的法律,例如大剂量和长期阿片类药物处方:(1)强制性处方药物监测计划(PDMP)注册法,要求处方医生在其所在州的 PDMP 中注册,PDMP 是患者受控物质处方的电子数据库,(2)强制性 PDMP 查询法,要求处方医生在开具阿片类药物之前查询 PDMP,(3)阿片类药物处方上限法,限制阿片类药物处方的剂量和/或持续时间,以及(4)药丸磨坊法,严格规范疼痛诊所以防止非医疗阿片类药物处方。一些疼痛专家担心这些法律可能会对慢性非癌痛患者的疼痛管理产生负面影响。本文描述了一项混合方法研究的方案,该研究分析了这四种法律对阿片类药物处方模式和慢性非癌痛治疗的独立影响,同时考虑了各州法律的实施和执行情况的变化。

方法

许多州在同一时间或前后颁布了多项阿片类药物处方法律。为了解决这个问题,我们的研究集中在 18 个治疗州,这些州在四年期间(法律颁布前/后两年)各颁布了一项单一的感兴趣的法律,没有其他可能混淆的法律。对 18 个治疗州的每一位关键领导人进行定性访谈,以描述每个州法律的实施和执行的时间、范围和力度。这些信息将为分析每两种类型的法律对两组结果(1)高风险阿片类药物处方和(2)慢性非癌痛的非阿片类药物治疗的影响的综合控制模型的设计和解释提供信息。

讨论

鉴于动态政策环境,每年都有许多州通过、修订、实施和执行各种法律来解决阿片类药物处方问题,对强制性 PDMP 注册、强制性 PDMP 查询、阿片类药物处方上限和药丸磨坊法律的研究是及时的。研究结果将为其他州制定、实施和执行这些法律提供信息。